{"id":"W2984096533","doi":"10.1101/832717","title":"Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in <i>BRCA1/2</i> -mutant metastatic breast cancer","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; National Institutes of Health; Sierra Oncology; PharmaMar; Daiichi-Sankyo; Foundation Medicine; MacroGenics; Puma Biotechnology; EMD Serono; Mersana Therapeutics; National Comprehensive Cancer Network; Fashion Footwear Association of New York; National Cancer Institute; Genomic Health; Yale University; U.S. Department of Defense; Breast Cancer Research Foundation; Yale Cancer Center; Pfizer; Dana-Farber/Harvard Cancer Center; Carrick Therapeutics; AstraZeneca; Eli Lilly and Company","keywords":"RAD51; Reversion; Cancer research; Breast cancer; PARP inhibitor; Homologous recombination; Germline mutation; Biology; Germline; Cancer; Mutation; DNA; Poly ADP ribose polymerase; Genetics; Gene; Polymerase","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002351506,0.0001321841,0.0002111045,0.0003237335,0.0001126807,0.0003107145,0.0001801492,0.0002192396,0.001240451],"category_scores_gemma":[0.0006086174,0.0001122773,0.0001578499,0.0001508813,0.0001390902,0.0001435183,0.0001336435,0.0002422444,0.0001610324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002724617,"about_ca_system_score_gemma":0.0001158422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003938207,"about_ca_topic_score_gemma":0.0004494427,"domain_scores_codex":[0.9998568,0.00002791172,0.00001297882,0.00004318561,0.00003191674,0.00002712308],"domain_scores_gemma":[0.9997137,0.00005652579,0.0001283738,0.00002890355,0.00002985081,0.00004268704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001706589,0.0001442991,0.4326093,0.000140702,0.000110711,0.00240244,0.0002200261,0.000663901,0.5202437,0.0003533954,0.0003673995,0.04103755],"study_design_scores_gemma":[0.00006904601,0.001945875,0.8249695,0.00002579438,0.0001142139,0.02336058,0.0002072193,0.002370089,0.1442079,0.0003754988,0.002339907,0.00001447195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985961,0.0005855863,0.0003179736,0.00002750012,0.000001918538,0.00000844933,0.0000728868,0.00001035908,0.0003792188],"genre_scores_gemma":[0.9993562,0.0001397124,0.0001956527,0.00001891718,0.000003387093,0.000005101031,0.0001084735,0.000003021923,0.000169576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001240451,"threshold_uncertainty_score":0.004149735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007687194024819561,"score_gpt":0.2221596438031271,"score_spread":0.2144724497783075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}